Latest Stories from Sciencedlvr.it Promoted Storieshttps://static.dlvr.it/images/d.pnghttps://static.dlvr.it/images/favicon.icotag:news.dlvr.it,2015-03-21:/category/science2015-03-21T19:11:43-07:00tag:news.dlvr.it,2015-03-21:3733232015-03-21T02:46:08-07:00]]>tag:news.dlvr.it,2015-03-20:3625122015-03-20T13:41:08-07:00
Paul Friedman to continue to serve as Executive Chairman and Bill
Rastetter to continue to serve as Lead Independent Director
]]>tag:news.dlvr.it,2015-03-20:3623422015-03-20T10:34:44-07:00
Plans for a New Customer Technical Center Unveiled
]]>tag:news.dlvr.it,2015-03-20:3563302015-03-20T07:45:16-07:00
Partnership will promote employee engagement and hands-on learning
experiences for students
]]>tag:news.dlvr.it,2015-03-20:3668892015-03-20T07:03:09-07:00]]>tag:news.dlvr.it,2015-03-20:3710002015-03-20T06:11:09-07:00
- Paper in Molecular Cell by Syros scientific founders
validates approach to therapeutic gene control in cancers with signaling
and transcriptional dependencies -
]]>tag:news.dlvr.it,2015-03-20:3593952015-03-20T05:01:43-07:00
Data to be Presented at American Association for Cancer Research 2015
Annual Meeting
]]>tag:news.dlvr.it,2015-03-20:3628932015-03-20T04:00:09-07:00
inviCRO expands 2D/3D histology imaging and analysis services for
research and drug development
]]>tag:news.dlvr.it,2015-03-19:3549362015-03-19T17:21:15-07:00
The world’s fastest game on ice comes to life in
all-new science based exhibit surrounding the Stanley Cup
success of the team
]]>tag:news.dlvr.it,2015-03-19:3588472015-03-19T17:17:19-07:00
Company authors peer-reviewed publication about lung cancer immune
therapy targeting the tumor endothelium
]]>tag:news.dlvr.it,2015-03-19:3732032015-03-19T13:43:09-07:00
“A Focus on Energy” jointly-sponsored by Rice University’s Center for
Computational Finance and Economic Systems (CoFES) and the Center for
Energy Studies (CES) at Rice University’s Baker Institute for Public
Policy
]]>tag:news.dlvr.it,2015-03-19:3652102015-03-19T13:16:08-07:00
Phase 1b/2 trial of CRLX101 in renal cell carcinoma achieves primary
endpoint
Closed debt facility for up to $26.0 million with Hercules Technology
Growth Capital in first quarter
]]>tag:news.dlvr.it,2015-03-19:3543572015-03-19T13:14:08-07:00
Preliminary top-line data demonstrate a median PFS of 9.9 months –
current standard of care is approximately 3.5 months
]]>tag:news.dlvr.it,2015-03-19:3540502015-03-19T11:30:08-07:00]]>tag:news.dlvr.it,2015-03-19:3620832015-03-19T11:13:09-07:00
Pivotal Data to be Presented at This Year’s American Academy of
Dermatology Meeting
]]>
]]>
Paul Friedman to continue to serve as Executive Chairman and Bill
Rastetter to continue to serve as Lead Independent Director
]]>
Plans for a New Customer Technical Center Unveiled
]]>
Partnership will promote employee engagement and hands-on learning
experiences for students
]]>
]]>
- Paper in Molecular Cell by Syros scientific founders
validates approach to therapeutic gene control in cancers with signaling
and transcriptional dependencies -
]]>
Data to be Presented at American Association for Cancer Research 2015
Annual Meeting
]]>
inviCRO expands 2D/3D histology imaging and analysis services for
research and drug development
]]>
The world’s fastest game on ice comes to life in
all-new science based exhibit surrounding the Stanley Cup
success of the team
]]>
Company authors peer-reviewed publication about lung cancer immune
therapy targeting the tumor endothelium
]]>
“A Focus on Energy” jointly-sponsored by Rice University’s Center for
Computational Finance and Economic Systems (CoFES) and the Center for
Energy Studies (CES) at Rice University’s Baker Institute for Public
Policy
]]>
Phase 1b/2 trial of CRLX101 in renal cell carcinoma achieves primary
endpoint
Closed debt facility for up to $26.0 million with Hercules Technology
Growth Capital in first quarter
]]>
Preliminary top-line data demonstrate a median PFS of 9.9 months –
current standard of care is approximately 3.5 months
]]>
Pivotal Data to be Presented at This Year’s American Academy of
Dermatology Meeting
]]>